Alumis (ALMS) Other Operating Expenses (2024 - 2025)
Alumis (ALMS) reported Other Operating Expenses of -$94.1 million for Q4 2025, up 45.31% year-over-year from -$64.8 million in Q4 2024, and up 9.91% quarter-over-quarter from -$104.5 million in Q3 2025.
Alumis (ALMS) Other Operating Expenses (2024 - 2025) Analysis & Trends
Alumis (ALMS) has 2 years of Other Operating Expenses data on file, last reported at -$94.1 million in Q4 2025.
- Other Operating Expenses for Q4 2025 came in at -$94.1 million, up 45.31% year-over-year; the trailing twelve-month figure through Dec 2025 was -$328.6 million (up 28.1% YoY), and the FY2025 annual result was -$475.1 million, down 20.53% from the prior year.
- Other Operating Expenses climbed to -$94.1 million in Q4 2025 per ALMS's latest filing, from -$104.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$94.1 million in Q4 2025 and troughed at -$172.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -94.10 Mn |
| Sep 30, 2025 | -104.45 Mn |
| Jun 30, 2025 | -130.00 Mn |
| Dec 31, 2024 | -172.05 Mn |
| Sep 30, 2024 | -141.67 Mn |
| Jun 30, 2024 | -143.21 Mn |